Results 191 to 200 of about 10,098 (247)

Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial. [PDF]

open access: yesJ Comp Eff Res
Vennin S   +8 more
europepmc   +1 more source

De-risking or recontracting – the risk dilemma of EU money laundering regulation

Journal of Risk Finance, 2020
Purpose Recent research and market effects within the European Union (EU) show a rising concern toward the de-risking of certain sectors/actors owing to the increased anti-money laundering regulation. Because of the enhanced due diligence and monitoring costs related to anti-money laundering and counter-terrorist financing regulation by the AMLD4 and ...
Kalle Johannes Rose
exaly   +2 more sources

De-risking renewable investments: Internalizing the risks and quantifying the impact of de-risking instruments

Renewable and Sustainable Energy Reviews
Mobilizing sufficient investment for renewable energy is critical to achieving global climate goals, yet high financing costs – primarily driven by risk perceptions – continue to hinder the deployment of variable renewables that are capital intensive, especially in emerging economies.
Behrang Shirizadeh, Johannes Trüby
exaly   +2 more sources

Home - About - Disclaimer - Privacy